CopyFind
Kaletra
medicine 📍 EU

Kaletra

Analogs of Kaletra

Find cheaper analogs and generic equivalents for Kaletra.

Ingredients

Active Ingredient: lopinavir;ritonavir


Product Overview

About Kaletra

Kaletra is an HIV medicine used in combination with other medicines to treat adults and children from over 14 days of age who are infected with HIV-1. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). Kaletra contains two active substances, lopinavir and ritonavir.

What it is used for

Kaletra is used to treat HIV-1 infection.

How it is used

Kaletra is available as tablets, capsules and oral liquid. The capsules and liquid must be taken with food, but the tablets can be taken with or without food. The medicine is taken once or twice daily in adults, and the dose depends on the type of virus the patient is infected with. In children, the dose depends on body weight and height. Kaletra can only be obtained with a prescription and should be prescribed by a doctor with experience treating HIV infection.

How it works

Both active substances in Kaletra are protease inhibitors: they block an enzyme called protease that is involved in the reproduction of HIV. When the enzyme is blocked, the virus does not reproduce normally slowing down its multiplication in the body. In Kaletra, lopinavir provides the activity against the virus while ritonavir mainly works as a ‘booster’ to slow down the rate at which lopinavir is broken down by the liver.

Active substance: lopinavir and ritonavir

Source: EMA EPAR

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.

Similar Products & Analogs

NORVIR

Active: RITONAVIR

Match: 100% Compare →
НОРВІР

Active: Ritonavir

Match: 100% Compare →
KALETRA

Active: LOPINAVIR, RITONAVIR

Match: 100% Compare →
РИТОВІР

Active: Ritonavir

Match: 100% Compare →
Ritonavir

Active: Ritonavir

Match: 100% Compare →
AURO-RITONAVIR

Active: RITONAVIR

Match: 100% Compare →
PAXLOVID

Active: RITONAVIR, NIRMATRELVIR

Match: 33% Compare →